AGP
Autumn Glory Partners’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.75M | Buy |
39,854
+3,724
| +10% | +$257K | 1.29% | 19 |
|
|
2025
Q1 | $2.37M | Buy |
36,130
+19,922
| +123% | +$1.3M | 1.17% | 21 |
|
|
2024
Q4 | $1.39M | Sell |
16,208
-6,463
| -29% | -$556K | 0.68% | 42 |
|
|
2024
Q3 | $2.7M | Buy |
22,671
+6,463
| +40% | +$770K | 1.04% | 25 |
|
|
2024
Q2 | $2.31M | Hold |
16,208
| – | – | 1.18% | 23 |
|
|
2024
Q1 | $2.08M | Sell |
16,208
-3,000
| -16% | -$385K | 1.02% | 29 |
|
|
2023
Q4 | $1.99M | Sell |
19,208
-820
| -4% | -$84.8K | 1.13% | 26 |
|
|
2023
Q3 | $1.82M | Buy |
20,028
+12,034
| +151% | +$1.09M | 1.11% | 29 |
|
|
2023
Q2 | $1.29M | Buy |
+7,994
| New | +$1.29M | 0.95% | 36 |
|
|
2023
Q1 | – | Sell |
-10,894
| Closed | -$1.47M | – | 167 |
|
|
2022
Q4 | $1.47M | Sell |
10,894
-217
| -2% | -$29.4K | 0.79% | 37 |
|
|
2022
Q3 | $1.11M | Buy |
11,111
+8,688
| +359% | +$866K | 0.75% | 44 |
|
|
2022
Q2 | $270K | Sell |
2,423
-11,732
| -83% | -$1.31M | 0.2% | 108 |
|
|
2022
Q1 | $1.57M | Sell |
14,155
-11,095
| -44% | -$1.23M | 0.91% | 33 |
|
|
2021
Q4 | $2.83M | Buy |
+25,250
| New | +$2.83M | 1.18% | 23 |
|